Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  79,584 results for ""Daunorubicin""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

CALCRL induces resistance to daunorubicin in acute myeloid leukemia cells through upregulation of XRCC5/TYK2/JAK1 pathway.

  • Authors : Tang S; Department of Hematology, the First Affiliated Hospital of Ningbo University.; Li S

Subjects: Daunorubicin*/Daunorubicin*/Daunorubicin*/pharmacology ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/genetics

  • Source: Anti-cancer drugs [Anticancer Drugs] 2024 Feb 01; Vol. 35 (2), pp. 163-176. Date of Electronic Publication: 2023 Nov 10.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Editorial & Opinion

Factors associated with inpatient mortality during daunorubicin and cytarabine induction in adults with acute myeloid leukemia-a national inpatient sample analysis.

Subjects: Daunorubicin*/Daunorubicin*/Daunorubicin*/therapeutic use ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy; Adult

  • Source: Annals of hematology [Ann Hematol] 2024 Feb; Vol. 103 (2), pp. 663-665. Date of Electronic Publication: 2023 Oct 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A comparative analysis of daunorubicin and its metabolite daunorubicinol interaction with apoptotic and drug resistance proteins using in silico approach.

  • Authors : Rai AK; Systems Toxicology and Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Lucknow, Uttar Pradesh, India.; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India.

Subjects: Daunorubicin*/Daunorubicin*/Daunorubicin*/pharmacology ; Daunorubicin*/Daunorubicin*/Daunorubicin*/therapeutic use ; Drug Resistance, Multiple*

  • Source: Journal of biomolecular structure & dynamics [J Biomol Struct Dyn] 2023 Dec; Vol. 41 (20), pp. 10737-10749. Date of Electronic Publication: 2023 Mar 12.Publisher: Taylor & Francis Country of Publication: England NLM ID: 8404176 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial.

  • Authors : Sierra J; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute. Universitat Autonoma of Barcelona, Barcelona, Spain.; Montesinos P

Subjects: Daunorubicin*/Daunorubicin*/Daunorubicin*/adverse effects ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/genetics

  • Source: Blood advances [Blood Adv] 2023 Nov 14; Vol. 7 (21), pp. 6441-6450.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

DeSUMOylation of chromatin-bound proteins limits the rapid transcriptional reprogramming induced by daunorubicin in acute myeloid leukemias.

Subjects: Daunorubicin*/Daunorubicin*/Daunorubicin*/pharmacology ; Daunorubicin*/Daunorubicin*/Daunorubicin*/therapeutic use ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy

  • Source: Nucleic acids research [Nucleic Acids Res] 2023 Sep 08; Vol. 51 (16), pp. 8413-8433.Publisher: Oxford University Press Country of Publication: England NLM ID: 0411011 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Inducing a Proinflammatory Response with Bioengineered Yeast Vacuoles with TLR2-Binding Peptides (Vac T2BP ) as a Drug Carrier for Daunorubicin Delivery.

  • Authors : Choi W; Graduate School of Semiconductor and Chemical Engineering, Jeonbuk National University, 567 Baekje-daero, Deokjin-Gu Jeonju, Jeonbuk 54896, South Korea.; Shin WR

Subjects: Drug Carriers* ; Daunorubicin*/Daunorubicin*/Daunorubicin*/administration & dosage ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/drug therapy

  • Source: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2023 Sep 06; Vol. 15 (35), pp. 41258-41270. Date of Electronic Publication: 2023 Aug 24.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101504991 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Rational Design of Daunorubicin C-14 Hydroxylase Based on the Understanding of Its Substrate-Binding Mechanism.

  • Authors : Zhang J; College of Biosystems Engineering and Food Science, Ningbo Research Institute, Zhejiang University, Hangzhou 310058, China.; School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW 2006, Australia.

Subjects: Daunorubicin*/Daunorubicin*/Daunorubicin*/metabolism ; Cytochrome P-450 Enzyme System*/Cytochrome P-450 Enzyme System*/Cytochrome P-450 Enzyme System*/metabolism; Molecular Docking Simulation

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 May 06; Vol. 24 (9). Date of Electronic Publication: 2023 May 06.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read More Add to Saved list
×
Academic Journal

Spectroscopic, calorimetric and cytotoxicity studies on the combined binding of daunorubicin and acridine orange to a DNA tetrahedron.

  • Authors : Zhang X; Institute of Biopharmaceutical Research, Liaocheng University, Hunan Road, Liaocheng 252059, China. Electronic address: .; Li X

Subjects: Daunorubicin*/Daunorubicin*/Daunorubicin*/pharmacology ; Daunorubicin*/Daunorubicin*/Daunorubicin*/chemistry ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology

  • Source: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2023 Jul 05; Vol. 295, pp. 122583. Date of Electronic Publication: Publisher: Elsevier Country of Publication: England NLM ID: 9602533 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3557

Record details

Read More Add to Saved list
×
Academic Journal

TRPC6 promotes daunorubicin-induced mitochondrial fission and cell death in rat cardiomyocytes with the involvement of ERK1/2-DRP1 activation.

  • Authors : Xu LX; The Key Laboratory of Fujian Province Universities on Ion Channel and Signal Transduction in Cardiovascular Diseases, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian Province, People's Republic of China.; Wang RX

Subjects: Daunorubicin*/Daunorubicin*/Daunorubicin*/toxicity ; Myocytes, Cardiac*/Myocytes, Cardiac*/Myocytes, Cardiac*/metabolism ; TRPC6 Cation Channel*/TRPC6 Cation Channel*/TRPC6 Cation Channel*/metabolism

  • Source: Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2023 Jul 01; Vol. 470, pp. 116547. Date of Electronic Publication: 2023 May 11.Publisher: Academic Press Country of Publication: United States NLM ID: 0416575 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Report

Venetoclax plus '2 + 5' modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single-centre retrospective analysis.

  • Authors : Wang H; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, P.R. China.; Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, P.R. China.

Subjects: Daunorubicin*/Daunorubicin*/Daunorubicin*/therapeutic use ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/etiology; Humans

  • Source: British journal of haematology [Br J Haematol] 2023 May; Vol. 201 (3), pp. 568-572. Date of Electronic Publication: 2023 Mar 02.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  79,584 results for ""Daunorubicin""